Insmed IncorporatedINSMNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +24.79% | +22.94% | +18.90% | +52.36% | +152.62% |
| Gross Profit Growth | +19.99% | +23.26% | +14.36% | +56.36% | +178.05% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +23.63% | +21.83% | +22.37% | +21.90% | +19.34% |
| Weighted Average Shares Diluted Growth | +23.63% | +21.83% | +22.37% | +21.71% | +19.34% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +26.28% | +28.48% | +36.56% | +54.21% | +170.82% |
| Inventory Growth | +18.41% | +21.40% | +19.48% | +22.84% | +33.97% |
| Asset Growth | +52.29% | +55.53% | +37.00% | +14.99% | +11.82% |
| Book Value per Share Growth | +0.00% | +0.00% | +2531.03% | +60.47% | +116.99% |
| Debt Growth | -3.54% | -4.46% | -46.11% | -35.97% | -41.55% |
| R&D Expense Growth | +31.16% | +26.01% | +20.74% | +23.61% | +41.83% |
| SG&A Expenses Growth | +59.18% | +58.48% | +45.22% | +56.71% | +49.10% |